Form 13-F position report

SPDR SERIES TRUST

Reported by Parkway Wealth Management Group LLC

XPH CUSIP 78464A722 Manager CIK 0002065679

First reported at 380,824 shares this quarter.

New
% of reported 13F value 2.85% This manager · Q3 2026
Shares 380,824 Quarter-end amount reported
Reported value $24,753,583 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 24753583

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for SPDR SERIES TRUST held by Parkway Wealth Management Group LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 380,824 +380,824 (0.0%) 2.85% $24,753,583 2026-10-19

Who else reported the position

127 managers reported SPDR SERIES TRUST for Q3 2026.

Managers reporting SPDR SERIES TRUST in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Bank of America Corporation Added 1,053,935 +38,041 < 0.01% $68,505,789 54 qtrs
MORGAN STANLEY Added 531,172 +216,946 < 0.01% $34,526,308 54 qtrs
WELLS FARGO & COMPANY MN Added 432,653 +45,285 < 0.01% $28,122,448 54 qtrs
ENVESTNET ASSET MANAGEMENT INC Added 388,701 +166,879 < 0.01% $25,265,575 5 qtrs
Parkway Wealth Management Group LLC This report New 380,824 +380,824 2.85% $24,753,583 1 qtr
Kingsview Wealth Management LLC Reduced 285,206 -29,688 0.22% $18,538,418 3 qtrs
LPL Financial LLC Added 179,499 +11,080 < 0.01% $11,667,448 54 qtrs
FIRST CITIZENS BANK & TRUST CO Reduced 170,502 -25,199 0.16% $11,082,630 28 qtrs
Private Advisor Group LLC Added 102,847 +39,150 0.02% $6,685,034 3 qtrs
Citigroup Inc Reduced 91,111 -13,003 < 0.01% $5,922,215 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 19, 2026
Filing type
13F-HR
Position type
ST STR SP PHARMA

Voting authority reported

Sole
0
Shared
0
None
380,824

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.